OncoMethylome Gains $2.7M for Women's Cancer Collaboration | GenomeWeb
NEW YORK (GenomeWeb News) — Belgium-based OncoMethylome Sciences has received a €1.95 million ($2.7 million) grant from the Belgian government to work on a collaborative project that will study women’s cancers and cancer vaccines, the company said today.
 
The four-year program, which includes research partners the University of Liege and GlaxoSmithKline, is funded with €3.5 million, of which €1.95 million goes to OncoMethylome and €1.55 million goes to the University of Liege.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.